CV Lattes
Secretaria da Saúde (São Paulo - Estado). Hospital das Clínicas da Faculdade de Medicina da USP (HCFMUSP). Instituto do Coração Professor Euryclides de Jesus Zerbini (INCOR) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Graduated in medicine at School of Medicine of the University of São Paulo. Residency in Internal Medicine at Hospital das Clínicas of the School of Medicine at University of Sao Paulo. Residency in Cardiology at the Heart Institute (InCor) of the School of Medicine of the USP. PhD in Sciences (Cardiology program) from the School of Medicine at USP. Postdoctoral research at the University of São Paulo. Collaborating Professor at the School of Medicine at USP. Coordinator of the Dyslipidemia and Atherosclerosis Prevention League at the School of Medicine at USP (activities of the league focused on undergraduate students in medicine and nutrition). Assistant Physician at the Lipid Clinical Unit of InCor-HC-FMUSP. Physician at the check-up Unit of Sírio Libanês Hospital. His research areas include: familial hypercholesterolemia, dyslipidemia, atherosclerosis, and cardiovascular prevention." (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Familial Hypercholesterolemia (FH) is a genetic disease, characterized by exposure to very high levels of LDL-cholesterol (LDL-c) throughout life and premature coronary heart disease. The clinical cardiovascular disease (CVD) risk calculation scores used in the general population are not capable of correctly estimating the risk of FH, since they underestimate these values. In this context…
Familial Hypercholesterolemia (FH) is a genetic disease, characterized by exposure to very high levels of LDL-cholesterol (LDL-c) throughout life and premature coronary disease. Clinical scores for calculating the risk of cardiovascular disease (CVD) used in the general population are not capable of correctly estimating the risk in FH, as they underestimate these values. In this context, …
| 3 / 2 | Completed scholarships in Brazil |
| Associated processes | |